Professional Advisory Board
Barry Bultz, PhD
Professor and Head, Division of Psychosocial Oncology, Daniel Family Leadership Chair in Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Dept of Psychosocial Oncology, Tom Baker Cancer Centre
Stephanie Cohen, MS, LCGC
Genetic Counselor, Ascension St. Vincent
Sanja Dacic, MD, PhD
Director of Pathology, University of Pittsburgh Medical Center
Christina M. Dieli-Conwright, PhD, MPH, FACSM
Physiologist, Dana-Farber Cancer Institute, Harvard Medical School
Bruce Edelen
Oncology Reimbursement Specialist, Oncology Reimbursement Management Inc.
Stephen Edge, MD
Surgical Oncologist, Roswell Park Comprehensive Cancer Center
Mary Lou Galantino, PT, MS, PhD, MSCE, FNAP, FAPTA
Distinguished Professor of Physical Therapy, Stockton University
Ashley Haggerty, MD, MSCE
Medical Director of Gynecologic Oncology, Riverview Medical Center
Karen Hurley, PhD
Clinical Psychologist and Hereditary Cancer Risk Specialist, Cleveland Clinic
Rupesh Kotecha, MD
Chief of Radiosurgery, Miami Cancer Institute
Thomas W. LeBlanc, MD, MA, MHS, FAAHPM
Blood Cancers Specialist, Duke University School of Medicine
Sharyn Lewin, MD
GYN Cancers Specialist, Holy Name Medical Center
John Marshall, MD
Director, The Ruesch Center for the Cure of GI Cancers, Frederick P Smith Endowed Chair, Chief, Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
Michele McCorkle, RN, MSN
Sr. Director, Clinical Data Services, Vidence
Mark A. O'Rourke, MD
Integrative Oncology, Co-chair, Palliative & EOL Care Committee, SWOG Cancer Research Network, Prisma Health Upstate Cancer Institute
Kristi Orbaugh, RN, MSN, RNP, AOCN
Oncology Nurse, Community Hospital Oncology Physicians
Kathryn Schmitz, PhD, MPH
Distinguished Professor of Public Health Sciences, Penn State College of Medicine
Neal Shore, MD
GU Cancers Specialist, Atlantic Urology Clinics
Christopher Spevak, MD, MPH, JD
Georgetown University Medical Center, Professor of Anesthesiology
John Sprandio Sr., MD
Hematology/Oncology, Main Line Health
Yousuf Zafar, MD, MHS, FASCO
Chief Quality & Innovation Officer, Associate Professor of Medicine, Public Policy, and Population Science, Duke Cancer Institute